Healthtech Startups

Curacle develops first-in-class therapies aimed at restoring microvascular function in aging and chronic diseases, including small molecules via its SOLVADYS platform and biologics via its EAGLES platform. Its pipeline addresses conditions such as macular degeneration.

1 investor

Cureverse is a global biotech company that discovers novel small-molecule drugs based on its proprietary "Right Structure" concept, targeting intractable diseases including dementia, cancer, and inflammatory conditions. The company aims to provide sustainable therapeutic solutions with improved efficacy, safety, and drug-like properties for patients with difficult-to-treat neurological and systemic diseases.

1 investor

PeproMene Bio develops platform and products targeting BAFF-R, an innovative tumor antigen for treating B cell malignancies and autoimmune diseases. The company focuses on immune therapies to address tumor relapse caused by antigen loss in patients with unmet medical needs.

1 investor

FutureChem develops and manufactures radiopharmaceuticals for diagnostic imaging, particularly for detecting Alzheimer's disease, Parkinson's disease, and various cancers. The company operates GMP-compliant production facilities across multiple sites in South Korea to supply medical institutions.

1 investor

Promedius offers an AI-powered diagnostic tool that analyzes chest X-rays to detect osteoporosis and assess bone health for clinicians and patients. The platform uses deep learning algorithms to automatically identify at-risk patients and generate clinical reports integrated into existing hospital imaging systems.

1 investor

ATLASTHEALTH, Inc. provides an online mental healthcare service in Japan that connects people with psychiatric conditions to online medical consultations, counseling, and return-to-work (reintegration) support as a single integrated system. The company aims to help patients access and continue treatment and re-enter the workforce, targeting people with mental disorders and employers dealing with workforce reintegration.

1 investor

A membership-based preventive healthcare service that pairs members with a team of specialized physicians for personalized medical consultation and ongoing health management before symptoms develop. The platform combines continuous monitoring of health metrics with lifestyle guidance from nutritionists and other specialists.

1 investor

Wellness Data operates JouleLife, a health coaching app paired with an original body composition scale and posture-support insole, helping users manage body shape and health metrics. It offers services to individuals as well as B2B health-management programs for companies and health insurance associations in Japan.

1 investor

Oncolys develops viral therapy drugs and treatments for cancer and severe viral infections, with a focus on oncolytic viruses and rare diseases. The company operates a hybrid business model combining licensing partnerships with pharmaceutical firms and direct commercialization of its own therapies.

1 investor

Carbgem (カーブジェン株式会社) is a Japanese company that applies generative AI, image AI, and cloud technology to build R&D and operational solutions, including drug discovery support, image and tissue analysis, quality control, medical document assistants, and diagnostic support. It serves life sciences, healthcare, consumer goods/distribution, manufacturing/infrastructure, and public/administrative sectors to address labor shortages, work standardization, and real-time decision-making.

1 investor

Callisto builds a medical imaging data infrastructure platform to support AI research and drug development by collecting, anonymizing, and structuring medical image data from Japanese healthcare facilities for use in AI model development and clinical research.

1 investor

Xirapha (operating under WeeMex Inc.) develops and operates cloud-based electronic health record systems and digital healthcare services for medical providers. The company's primary offering is Kirin Karute, a free cloud-based electronic medical records platform.

1 investor

Clipla develops cloud-based electronic medical record systems for specialized medical practices including ophthalmology, obstetrics/gynecology, and otolaryngology.

1 investor

ClinCloud provides cloud-based solutions for collecting clinical trial data, aimed at improving the efficiency of data collection in drug development for pharmaceutical companies and research institutions. It also runs a CRO business covering data management and statistical analysis, and is based in Tokyo, Japan.

1 investor

Cozre operates a media and market research platform serving parents and caregivers in Japan, providing data-driven insights into parenting trends, consumer behavior, and family-related products and services. The company has grown from a small media outlet to a community of over 900,000 member households, offering awards, market research reports, and marketing research services focused on the parenting and women's career development sectors.

1 investor

Kolagen Pharma develops and sells pharmaceuticals, medical devices, and research reagents, and manufactures cosmetics, focusing on collagen-based biomaterials for regenerative medicine. Founded by university researchers in science and pharmacology, it is based within Kyoto University's medical research facilities in Japan.

1 investor

GeCS provides a mobile application for patients to manage and understand their medical information, prescriptions, and treatment history. The company aims to ensure equitable access to appropriate healthcare by simplifying the patient journey and reducing information gaps between medical professionals and patients.

1 investor

Joshu develops a healthcare information sharing platform that connects care providers and facilities to support integrated community-based care systems.

1 investor

CellGen Tech develops cell-based medicines for rare and intractable diseases by engineering human adipose cells to produce therapeutic proteins. The company focuses on treating conditions caused by missing or deficient enzymes and proteins, with partnerships involving university medical experts.

1 investor

Cellspect develops next-generation clinical diagnostic reagents and in-vitro diagnostic products based on deep-tech, covering diagnostic technologies from biomarker discovery to treatment monitoring. It offers open-innovation partnerships with pharmaceutical companies and medical institutions, including point-of-testing and precision oncology products, based in Iwate, Japan.

1 investor

T Cell Nouveau develops Hybrid CAR-T cell therapies designed to treat solid tumors by enhancing immune system activation in suppressive tumor microenvironments. The clinical-stage biopharmaceutical company targets cancer patients and originated from research conducted at Mie University's Personalized Cancer Immunotherapy department.

1 investor

Nagasuna Mayu develops and manufactures silk protein products (sericin and fibroin) for application in cosmetics, healthcare, and materials, along with textile refining machinery. The company operates multiple facilities in Kyoto Prefecture, Japan, focusing on innovation in silk-based biotechnology.

1 investor

A digital solutions company providing medical and healthcare information access for physicians, healthcare institutions, and pharmaceutical companies in Japan.

1 investor

A Japanese biotech company developing regenerative medicine technology (iBTA / in-Body Tissue Architecture) that grows the patient's own tissue to form implantable structures such as Biotube and Biosheet. Its applications include treatments for conditions like severe diabetic foot ulcers and gangrene.

1 investor